#mcconverge: Become Trend on twitter at (2018-07-12 14:01)


People talking about #mcconverge: - erindietsche - BonnieAndDx - PedagogyCE - pdpilch - medcitynews - Biocyclist - BunnyEllerin - cubismi_inc - cubismi_inc - DNAed_tech[...]
- ArielMedicine - pdpilch - pdpilch - BunnyEllerin - BunnyEllerin - HSLavoie - seriousssam - seqster - nobismhealth - erindietsche - aparmarbb - erindietsche - heshnarayanan - Telmediq - robertwdubois - erindietsche - ChrisPascale6 - StephenJWillia2 - erindietsche - innovaccer - innovaccer - medcitynews - erindietsche - ChrisPascale6 - medcitynews - heshnarayanan - innovaccer - erindietsche - hcinterop_guy - heshnarayanan - SarahfromHU - markpun - StephLBaum - UM_VBID - erindietsche - andrewchap361 - ECRI_Institute - JoyceLang1 - Mahek_MD - heshnarayanan - npcnow - npcnow - hofelicha - npcnow - aparmarbb - danleonardnpc - medcitynews - 3Derm - ArghyaM00815653 - npcnow - heshnarayanan - AriaMarketing - hofelicha - npcnow - npcnow - StephenJWillia2 - Biocept - ECRI_Institute - heshnarayanan - DrNgoziOnuoha - ECRI_Institute - heshnarayanan - ECRI_Institute - CareAlineTweet - CareAlineTweet - npcnow - StephenJWillia2 - medcitynews - erindietsche - Veracyte - ChrisPascale6 - erindietsche - erindietsche - hofelicha - cm_greenwood - erindietsche - healthverity - ChrisPascale6 - HSLavoie - erindietsche - markpun - heshnarayanan - CareAlineTweet - erindietsche - medcitynews - AntonioTedesco - heshnarayanan - billstro4 - chrisseper - Biocept

This Tag appearing in: United States: ( Philadelphia - ).
Popular tweets tagged with #mcconverge:
#mcconverge Mahesh Narayanan @heshnarayanan🔁Looking forward to Day 2 of #mcconverge @medcitynews
loading...
#mcconverge Mahesh Narayanan @heshnarayanan🔁Breaking down silos in #cancerresearch @seqster @pfizer @HealthShareExch @innovaccer #mcconverge
#mcconverge ECRI Institute @ECRI_Institute🔁Shannah moderates #MCConverge session on liquid biopsy and #Genetictesting versus reimbursement hurdles
#mcconverge CareAline® @CareAlineTweet🔁“We believe the future of triage is automated”- Liz Asai, 3Derm
@liz_asai @medcitynews #MCConverge
#mcconverge Erin Dietsche @erindietsche🔁.@annewellagain closes out #mcCONVERGE in #Philadelphia
#mcconverge Mahesh Narayanan @heshnarayanan🔁#Remission is not well again @annewellagain #mcconverge #PatientExperience #patientvoice #cancer
#mcconverge nobism @nobismhealth🔁 #Remission is not well again @annewellagain #mcconverge #PatientExperience #patientvoice #cancer
Erin Dietsche @erindietsche🔁Are we spending too much money on #cancer compared to other #diseases? #mcCONVERGE #healthcare medcitynews.com
Bonnie Anderson @BonnieAndDx🔁How can we best disrupt healthcare to create better outcomes and lower cost? At Veracyte, we identify the point in t twitter.com he existing process where our tests will be most easily integrated to address existing clinical problems.
PedagogyOnline#CE. @PedagogyCEWhat goes into mission based partnerships? Learn more at ... 🔁 Learning how partnered with to provide new chest & port access hoodies. 👚👕
Patrick D Pilch @pdpilch🔁Thank you for the shoutout to me for my panel yesterday!

Gamechanger discusses value-based pricing for oncology drugs.


MedCity News @medcitynews🔁Thanks to & my co-panelists Patrick Davish Gary Kurzman & Steven Lucio for hosting a lively discussion on drugs, pricing & access!
Biocyclist @Biocyclist🔁 The person is at the center of disrupting all the silos in #healthcare, says @seqster CEO Ardy Arianpour at #mcCONVERGE
Cubismi, Inc. @cubismi_inc🔁 As much as we talk about #collaboration, we’re still in #silos and not sharing #data, says Ankur Parikh at #mcCONVERGE
Cubismi, Inc. @cubismi_inc🔁Our panel now talking about Breaking Down Silos in Cancer Research at What are the biggest barriers?
Genomics Edtech @DNAed_tech🔁Providers and payers seek to leverage consumer interest in genetic testing to spur advances in precision medicine.
Patrick D Pilch @pdpilch🔁.⁦⁩ moderates fascinating talk on drug pricing w/ Patrick Davish ⁦⁩ ⁩ of Natl Pharmaceutical Council, Gary Kurtzman ⁦⁩ and Steven Lucio ⁦ ⁩
Heather S Lavoie @HSLavoie🔁Providers and payers seek to leverage consumer interest in genetic testing to spur advances in precision medicine. twitter.com
Samer Sabri @seriousssam🔁“We believe the future of triage is automated”- Liz Asai, 3Derm

Erin Dietsche @erindietsche🔁At #MCConverge,@annewellagain talks about how she related to #LordOfTheRings on her #cancer journey.
Arundhati Parmar @aparmarbb🔁Anne Stockwell, a 3-time cancer survivor shares how the strategies to manage cancer for her fell far short of the ove twitter.com rwhelming fear she felt
Erin Dietsche @erindietsche🔁Post-traumatic stress makes #cancer cost more, says @annewellagain at #mcconverge
Bobby Dubois @robertwdubois🔁Thanks to & my co-panelists Patrick Davish Gary Kurzman & Steven Lucio for hosting a lively discussion on drugs twitter.com , pricing & access!
Christiana Pascale @ChrisPascale6🔁Panel on breaking down silos in research: panel says cancer more willingly share their data. B/c cancer sucks; and twitter.com if one persons data has a chance at helping others, that’s something.
Stephen J Williams @StephenJWillia2🔁Live Conference Coverage 2018 : Promising Drugs and Breaking Down Silos via twitter.com
Erin Dietsche @erindietsche🔁The person is at the center of disrupting all the silos in #healthcare, says @seqster CEO Ardy Arianpour at #mcCONVERGE
Innovaccer @innovaccer🔁Three levels of in : Technical, semantic and syntactical - David Nace
Innovaccer @innovaccer🔁 #Healthcare #data is a mess to deal with, says @innovaccer’s David Nace at #mcconverge
MedCity News @medcitynews🔁Here's the thing on working in : it's personal. Everyone's drive for what they do is a direct result of their (or a family member) experience in the system. It touches you, and being part of a group that is so relentlessly driven to do better is inspiring.
Erin Dietsche @erindietsche🔁#Healthcare #data is a mess to deal with, says @innovaccer’s David Nace at #mcconverge
Christiana Pascale @ChrisPascale6🔁So, I know food at conferences is a thing. I’ll say this: the team knows their audience/ snacks! twitter.com
MedCity News @medcitynews🔁Our panel now talking about Breaking Down Silos in Cancer Research at What are the biggest barriers? twitter.com
Mahesh Narayanan @heshnarayanan🔁Three levels of #interoperability in #healthcare : Technical, semantic and syntactical - David Nace #mcconverge @innovaccer
Innovaccer @innovaccer🔁Speakers from , , and discuss and breaking down silos in at
Erin Dietsche @erindietsche🔁Speakers from , , and discuss and breaking down silos in at twitter.com
John Donnelly @hcinterop_guy🔁 Innovation and R&D Lead, adds the HIE perspective to the opportunities for better info exchange f cancer care twitter.com
Sarah W HU @SarahfromHU🔁Fantastic break-out panel discussion at with Health Union's very own !
Stephanie Baum @StephLBaum🔁.⁦⁩ moderates fascinating talk on drug pricing w/ Patrick Davish ⁦⁩ ⁩ of Natl Pharmaceutical Council, Gary Kurtzman ⁦ twitter.com ⁩ and Steven Lucio ⁦ ⁩
UM V-BID Center @UM_VBID🔁At talking abt & value assessment frameworks. We've explored how they can improve, meet challenges via
Erin Dietsche @erindietsche🔁Too much money being spent on cancer treatment, a disease for the old. Should we treat diseases that affect young people more? Interesting pov from Robert Dubois,
loading...
Andrew Chapman @andrewchap361🔁., Chief of Cancer Services of will be speaking today at — check out the JeffDESIGN
ECRI Institute @ECRI_Institute🔁Today! Don't miss Robertson at speaking on the Impact of Third Party Health Technology Assessments on Market Access #MCConverge
Mahek A. Shah, M.D. @Mahek_MD🔁Thank you for the shoutout to me for my panel yesterday!

Gamechanger discusses value-based pricing for oncology twitter.com drugs.


Mahesh Narayanan @heshnarayanan🔁What percentage of the that is brought to the do the drug development companies deserve to collect? twitter.com
NPC @npcnow🔁At talking abt & value assessment frameworks. We've explored how they can improve, meet challenges via twitter.com
NPC @npcnow🔁The full conversation was about how we are spending our resources & what is low/high value care so that we get the b twitter.com est outcomes.
Andrea Hofelich @hofelicha🔁We need to consider how we are spending our resources & what is low/high value care. twitter.com
NPC @npcnow🔁 explains the barriers in developing value- and outcomes-based agreements in the US twitter.com
Arundhati Parmar @aparmarbb🔁Too much money being spent on cancer treatment, a disease for the old. Should we treat diseases that affect young peo twitter.com ple more? Interesting pov from Robert Dubois,
Dan Leonard @danleonardnpc🔁At , discussing President’s Cancer Panel report. It cites proposals incl outcomes-based contracting, value assessment best practices, & incentives to use high-value meds & minimize out-of-pocket costs
MedCity News @medcitynews🔁Too much money being spent on cancer treatment, a disease for the old. Should we treat diseases that affect young peo twitter.com ple more? Interesting pov from Robert Dubois,
NPC @npcnow🔁At , discussing President’s Cancer Panel report. It cites proposals incl outcomes-based contracting, value assessmen twitter.com t best practices, & incentives to use high-value meds & minimize out-of-pocket costs
Mahesh Narayanan @heshnarayanan🔁As we begin to better understand and get more data on outcomes for , will come down for brand names and twitter.com generics, increasing access.
Andrea Hofelich @hofelicha🔁 discussion on drugs, pricing & access w/ Patrick Davish Gary Kurzman & Steven Lucio starting now
NPC @npcnow🔁 notes that we need to ask tough questions about & how we invest in health; that’s why the National Pharmaceutical C twitter.com ouncil is leading an initiative to examine those issues
NPC @npcnow🔁 discussion on drugs, pricing & access w/ Patrick Davish Gary Kurzman & Steven Lucio starting now twitter.com
Stephen J Williams @StephenJWillia2🔁Live Conference Coverage 2018 Philadelphia:Liquid Biopsy and Gene Testing vs Reimbursement Hurdles via twitter.com
Biocept @Biocept🔁 are difficult because of not always getting enough tissue and physical pain for patients, so can complement in identifying alternative for better care
ECRI Institute @ECRI_Institute🔁Today - don't miss Roth moderating - Liquid Biopsy and Gene Testing vs. Reimbursement Hurdles. Covering twitter.com
Mahesh Narayanan @heshnarayanan🔁 are difficult because of not always getting enough tissue and physical pain for patients, so can complement in id twitter.com entifying alternative for better care
CareAline® @CareAlineTweet🔁The of : How are advancing ? via
NPC @npcnow🔁Relevant to discussion on gene testing, reimbursement hurdles: our study w/ on addressing the financial challenges twitter.com associated with gene therapy. Check it out via Blog
Stephen J Williams @StephenJWillia2🔁Live Conference Coverage 2018 : The Davids vs. the Cancer Goliath Part 2 via twitter.com
MedCity News @medcitynews🔁The of : How are advancing ? via twitter.com
Erin Dietsche @erindietsche🔁One #mcCONVERGE panel focused on how #valuebasedcare and #oncology come together in the #healthcare ecosystem medcitynews.com
Veracyte, Inc. @Veracyte🔁“In today’s healthcare world, if you’re not changing practice in a way that’s benefiting patients and physicians and twitter.com taking significant cost out of the healthcare system, you may as well save your investment.” @ 2018
Christiana Pascale @ChrisPascale6🔁Here's the thing on working in : it's personal. Everyone's drive for what they do is a direct result of their (or a twitter.com family member) experience in the system. It touches you, and being part of a group that is so relentlessly driven to do better is inspiring.
Erin Dietsche @erindietsche🔁.@PotentiaMetrics is developing personalized and #predictive #AI platforms. #mcconverge
Erin Dietsche @erindietsche🔁#CytoSavvy’s platform is focused on #digital #pathology. #MCConverge
Andrea Hofelich @hofelicha🔁It’s exciting to learn about what’s possible in #health data to improve #patient outcomes! #mcconverge twitter.com
Claire Greenwood @cm_greenwood🔁Anthony Green at represents , one of our Power of Nine in our Collaborative, BFTP has invested in ’s NICUtrition —
Erin Dietsche @erindietsche🔁.@cubismi_inc wants to create a 3D #precision zoomable #body map. #mcconverge
HealthVerity @healthverity🔁Kicking off Day 2 at MedCity Converge - if you haven't yet, stop by the @healthverity table to meet our team! #mcconverge
Christiana Pascale @ChrisPascale6🔁Loving this David vs. Cancer Goliath start up rapid fire session at #MCConverge !
Heather S Lavoie @HSLavoie🔁I was honored to spend time at today, discussing the exciting progress we’ve made toward identifying diseases earlier through biomarkers and non-invasive testing. Thanks , Heather Rose, @parmarbb and !
Erin Dietsche @erindietsche🔁.@cns_pharma’s focus is on #glioblastoma. #mcconverge
Mark Punyanitya @markpun🔁., , , and CytoSavvy are the presenting at during part 2 of the Davids vs. the Goliath session.
Mahesh Narayanan @heshnarayanan🔁#Startup Davids vs #Cancer Goliath Part 2 #mcconverge @3Derm @cns_pharma @cubismi_inc #CytoSavvy @PotentiaMetrics
Erin Dietsche @erindietsche🔁.@3Derm wants to increase #Dermatology access. #mcconverge
MedCity News @medcitynews🔁., , , and CytoSavvy are the presenting at during part 2 of the Davids vs. the Goliath session. twitter.com
Antonio Tedesco @AntonioTedesco🔁Arundhati Parmar kicking off Day Two of MedCity CONVERGE 2018 @medcitynews #mcconverge lnkd.in
Biocept @Biocept🔁In many cases, patients are left to pay for expensive genetic testing themselves. Michael Nall, Biocept’s president & twitter.com CEO, will be sharing his take on how this dynamic can be shifted today at 9:30 a.m. at CONVERGE.

05

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive